Organophosphate Poisoning With Delayed Intermediate Syndrome: A Narrative Review

Abstract

Organophosphate pesticide poisoning is a leading cause of death from self-harm in rural parts of the world, and survivors of the first cholinergic crisis can still die or be ventilated for days because of a second problem, the intermediate syndrome. First described in the 1970s and named in 1987, this syndrome appears after the acute features have settled and is marked by weakness of the neck flexors, proximal limb muscles, muscles supplied by cranial nerves and, most dangerously, the muscles of breathing. This narrative review describes what the published literature says about its recognition, its probable mechanisms, the compounds and treatment patterns associated with it, and its place among the other neurological consequences of organophosphate exposure. It reports no patient data and no new analysis. The evidence shows a clear clinical picture but a weak causal story: prolonged inhibition of acetylcholinesterase and changes at the nicotinic receptor are plausible, yet no single mechanism has been proved, and the effect of oxime and atropine regimens on its occurrence remains contested because the trials are small, differ in design and use varied definitions. Prospective cohorts suggest the syndrome is better thought of as a spectrum than as an all-or-nothing event, which makes incidence figures hard to compare. The review concludes that planned, repeated bedside examination after the acute phase is the best-supported safeguard, and it lists the design features that future studies would need.